Clinuvel Pharmaceuticals Financial Data

Company name:Clinuvel Pharmaceuticals LtdStatus:Active
End of fiscal year:June 29 2018ISINAU000000CUV3
Auditor:Grant ThorntonYear established:1999
Company sector name:HealthcareTrading currency:AUD
Industry name:BiotechnologyPlace of incorporation:Australia (AU)
Industry group nameBiotechnologyDoing business in:Australia (AU)
Address15 Queen Street
Level 6, 3000
Tel.:+61 396604900
City/Country:Melbourne, AustraliaFax:+61 396604999
Web address:http://www.clinuvel.com
Company description:Clinuvel Pharmaceuticals Ltd is a biopharmaceutical company. It is engaged in developing drugs for the treatment of skin disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Clinuvel’s pioneering work aims at preventing the symptoms of skin diseases related to the exposure to harmful UV radiation and at repigmentation of the skin due to a number of depigmentation disorders.
Price Price change [%] Bid Offer Open High Low Volume
16.36  0.07[0.43%] 16.36 16.39 16.17 16.72 15.66 50,435
Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
777.73026087 48.960633 0.64 0.28 - 58.81 - 14.50 - 44.67

CUV KEY FIGURES (at previous day's close)

Yesterday's Close
16.29
PE Ratio
58.81
Market Capitalisation
777.73M
Latest Shares Outstanding
48.96M
Earnings pS (EPS)
0.28
Dividend pS (DPS)
-
Dividend Yield
-
Sales per Employee
-
Effective Tax Rate
-
Foreign Sales
-
Domestic Sales
-
Selling, General & Adm/tive (SG...
4.12%
Research & Devlopment (R&D) as ...
0.00%
Gross Profit Margin
76.52%
EBITDA Margin
47.84%
Pre-Tax Profit Margin
50.78%
Assets Turnover
1.68%
Return on Assets (ROA)
0.37%
Return on Equity (ROE)
0.41%
Return on Capital Invested (ROC...
0.40%
Current Ratio
12.18
Leverage Ratio (Assets/Equity)
1.09%
Interest Cover
-
Total Debt/Equity (Gearing Rati...
-
LT Debt/Total Capital
-
Working Capital pS
0.83
Cash pS
0.76
Book-Value pS
0.89
Tangible Book-Value pS
0.01
Cash Flow pS
-
Free Cash Flow pS
0.24
Spread
0.03
Gross gearing
0.00%
Net Debt
-36.20M

CUV Balance Sheet Chart (June 29 2018)

:liab eq:assets
Period High Low
1 Week17.0014.55
1 Month18.2414.50
3 Months22.0914.50
6 Months32.1314.50
1 Year44.6714.50
3 Years45.8812.92
5 Years45.885.91

Share price performance previous 3 years

Share price performance intraday

Period Open Open Avg. VWAP Min Vol Max Vol Avg. Daily Vol Change %
1 Week15.4615.95216.0091,580238,842135,8060.905.82%
1 Month17.5616.100616.0978,501238,842115,453-1.20-6.83%
3 Months21.6417.998718.2770,348354,936136,696-5.28-24.4%
6 Months32.1022.413422.0123,451354,936126,398-15.74-49.03%
1 Year29.2628.042728.8423,451754,338130,523-12.90-44.09%
3 Years33.7126.251826.726,1421,866,183172,831-17.35-51.47%
5 Years7.0120.934525.171,7711,866,183124,6099.35133.38%

CUV Growth Ratios (June 29 2018)

1 year 3 years 5 years 10 years
Diluted EPS growth
0.87
-
-
-
Diluted continuous EPS growth
0.87
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
0.55
0.49
0.18
-0.07
Revenue growth
0.52
1.06
0.75
-
Operating income growth
0.81
-
-
-
Net income growth
0.84
-
-
-
Net income cont growth
0.84
-
-
-
CFO growth
0.18
-
-
-
FCF growth
0.18
-
-
-
Operating revenue growth
0.52
1.06
0.75
-

CUV Income Statement June 29 2018 (AUD)

Total Revenue
25.485673
Operating Revenue
25.485673
Cost of Revenue
5.985305
Gross Profit
19.500368
Operating Expenses
7.308252
Selling,General and Administr...
1.051125
Selling and Marketing Expense
1.051125
Other Operating Expenses
6.257127
Operating Income
12.192116
Interest Income/Expense,Net-N...
0.264452
Interest Income-Non Operating
0.264452
Other Income/Expense,Net
0.485838
Other Non-Operating Income/Ex...
0.485838
Pretax Income
12.942406
Provision for Income Tax
-0.281779
Net Income Available to Commo...
13.224185
Net Income
13.224185
Net Income Including Noncontr...
13.224185
Net Income from Continuing Op...
13.224185
Basic EPS
0.28
Basic EPS from Continuing Ope...
0.28
Basic EPS from Discontinued O...
0.00
Diluted EPS
0.27
Diluted EPS from Continuing O...
0.27
Diluted EPS from Discontinued...
0.00
Basic Weighted Average Shares...
47.742803
Diluted Weighted Average Shar...
49.5287827715
Net Income from Continuing an...
13.224185
Normalized Income
13.224185
Basic EPS,Continuing and Disc...
0.28
Diluted EPS,Continuing and Di...
0.27
Interest and Dividend Income
0.264452
Net Interest Income
0.264452
Earning Before Interest and T...
12.192116
Earning Before Interest Tax D...
12.192116
Cost of Revenue,Reconciled
5.985305
Net Income from Continuing Op...
13.224185
Normalized Basic EPS
0.28
Normalized Diluted EPS
0.27
NormalizedEBITDA
12.192116
Tax rate for calculations
0.02

CUV Efficency Ratios (June 29 2018)

Days in sales
56.59
Days in inventory
57.41
Days in payment
30.74
Cash conversion cycle
83.27
Receivable turnover
6.45
Inventory turnover
6.36
Payable turnover
11.88
Fixed assets turnover
166.53
Assets turnover
0.71
ROE
0.41
ROA
0.37
ROIC
0.40
FCF sales ratio
0.46
FCF net income ratio
0.88
Capital expenditure sales ratio
0.00

CUV Financial Health Ratios (June 29 2018)

Current ratio
12.18
Quick ratio
11.90
Debt total capital ratio
-
Debt equity ratio
-
Financial leverage
1.09
Total debt to equity
-

CUV Avearge Growth Ratios Over 5 Years (June 29 2018)

Growth ann capital spending
0.19
Growth ann gross profit
0.66
Avg gross margin
0.31
Avg post tax margin
-1.13
Avg pre tax marginr
-1.13
Avg net profit
-1.13
Avg ret commonr
-0.13
Avg ret assets
-0.11
Avg ret invested capital
-0.14

CUV Profitability Ratios (June 29 2018)

Gross margin
0.77
Operating margin
0.48
EBT margin
0.51
Tax rate
-
Net margin
0.52
Sales per employee
-
EBIT margin
0.48
EBITDA margin
0.48
Normalized net profit margin
0.52
Interest coverage
-
Inc per employee tot ops
-

CUV Valuation Ratios (June 28 2018)

Sales per share
0.33
Growth ann sales per share 5 ye...
-
Book value per share
0.57
CF per share
0.16
Price to EPS
93.46
Ratio PE 5 year high
114.58
Ratio PE 5 year low
7.46
Price to book
19.27
Price to sales
33.90
Price to cash flow
69.44
Price to free cash flow
69.93
Div rate
0.02
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
0.00
Sustainable growth rate
0.28
Cash return
0.02

CUV Balance Sheet June 29 2018 (AUD)

Total Assets
42.904617
Current Assets
42.269069
Cash,Cash Equivalents,and Sho...
36.198451
Cash and Cash Equivalents
36.198451
Cash
16.629449
Cash Equivalents
19.569002
Receivables
5.090271
Accounts Receivable
4.937083
Other Receivables
0.153188
Inventories
0.641285
Raw Materials
0.454257
Finished Goods
0.334916
Inventories Adjustments/Allow...
-0.147888
Prepaid Assets and Others
0.339062
Total Non-Current Assets
0.635548
Net Property,Plant,and Equipm...
0.168739
Gross Property,Plant,and Equi...
0.312221
Machinery,Furniture/Equipment
0.187032
Other Properties
0.125189
Accumulated Depreciation
-0.143482
Goodwill and Other Intangible...
0.18503
Goodwill
0.18503
Deferred Non-Current Assets
0.281779
Deferred Taxes,Non-Current As...
0.281779
Total Liabilities
3.488629
Current Liabilities
3.470821
Payables and Accrued Expenses
2.499915
Payables
2.499915
Accounts Payable
0.428562
Other Payable
2.071353
Pension and Other Post-Retire...
0.970906
Total Non-Current Liabilities
0.017808
Provisions,Long Term
0.014611
Employee Benefits
3,197.00
Pension and Other Postretirem...
3,197.00
Total Equity
39.415988
Stockholder's Equity
39.415988
Capital Stock
148.614908
Common Stock
148.614908
Retained Earnings
-112.680836
Accumulated Gains/ Losses Not...
3.481916
Foreign Currency Translation ...
0.618015
Other Equity Adjustments
2.863901
Total Capitalization
39.415988
Common Stock Equity
39.415988
Net Tangible Assets
39.230958
Working Capital
38.798248
Invested Capital
39.415988
Tangible Book Value
39.230958
Ordinary Shares Number
47.824427
TotalLiabilitiesAsReported
3.488629
TotalEquityAsReported
39.415988

CUV Cash Flow June 29 2018 (AUD)

Classes of Cash Receipts from...
23.758447
Receipts from Customers
23.705378
Receipts from Government Gran...
0.053069
Classes of Cash Payments
-12.539522
Payments to Suppliers for Goo...
-12.539522
Interest Received, Direct
0.290566
Taxes Refund/Paid, Direct
0.183842
Cash Flow from Investing Acti...
-0.075123
Cash Flow from Continuing Inv...
-0.075123
Purchase/Sale of Property,Pla...
-0.075123
Purchase of Property,Plant an...
-0.075123
Cash and Cash Equivalents,End...
36.198451
Change in Cash
11.61821
Effect of Exchange Rate Chang...
0.827929
Cash and Cash Equivalents,Beg...
23.752312
Capital Expenditure
-0.075123
Free Cash Flow
11.61821
ChangeinCashSupplementalAsRep...
11.61821


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.